Camber Capital Management LP's Net Worth
$0
Estimate Recalculated Nov 5, 2024 05:01PM EST
Who is Camber Capital Management LP?
Camber Capital Management LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cardiovascular Systems Inc, Protalix BioTherapeutics, Inc., AMAG PHARMACEUTICALS, INC., SEQUENOM INC, ENDOLOGIX INC /DE/, WORLD HEART CORP, and ZimVie Inc..
SEC CIK
Camber Capital Management LP's CIK is 0001444043
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cardiovascular Systems Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.83% | -1.10M |
$23.26 | -$25,591,497.50 | 3M |
Sep 19 - Sep 20
| |||
Form 4
| +6.49% | 250K |
$7.55 | $1,888,725.00 | 4.1M |
Feb 23
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protalix BioTherapeutics, Inc. (PLX) Snapshot price: $1.001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.83% | -2.50M |
$0.32 | -$792,000.00 | 10.78M |
Dec 2
| |||
Form 4
| +43.13% | 4M |
$1.00 | $4,000,435.69 | 13.28M |
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMAG PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.39M |
$13.57 | -$59,586,787.00 |
0
|
Oct 1
| |||
Form 4
| +9.61% | 385K |
$7.87 | $3,029,791.94 | 4.39M |
Aug 7 - Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SEQUENOM INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.99% | 665.43K |
$1.62 | $1,078,398.94 | 17.32M |
Dec 30 - Jan 4
| |||
Form 4/A
| +2.89% | 468K |
$1.30 | $609,745.20 | 16.66M |
Dec 14 - Dec 16
| |||
Form 4
| +2.89% | 468K |
$1.30 | $609,737.20 | 16.66M |
Dec 14 - Dec 15
| |||
Form 4
| +2.58% | 791.57K |
$1.29 | $1,027,048.71 | 31.47M |
Dec 8 - Dec 10
| |||
Form 4
| +5.77% | 1.65M |
$1.99 | $3,242,003.84 | 30.24M |
Oct 6 - Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENDOLOGIX INC /DE/ No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||